CSIMarket
 




Lexaria Bioscience Corp   (LEXX)
Other Ticker:  
 
 



LEXX Price to Sales Ratio (Nov 30 2023) (Aug 31 2023) (May 31 2023) (Feb 28 2023) (Nov 30 2022)
Sales Trailing 12 Months I. Quarter IV. Quarter III. Quarter II. Quarter I. Quarter
Price to Sales (TTM) Ratio current            -            -            15.88            46.14            45.02
Revenue TTM Y / Y Change - % - % 97.23 % 25.34 % -21.9 %
Revenue Y / Y Change 49.08 % - % -6.59 % 14.24 % 631.1 %
Stock performance to date 161.38 % 63.31 % -55.19 % -33.44 % 45.91 %

Price to sales ratio Comment
Lexaria Bioscience Corp recorded loss in trailing twelve months.

Within Healthcare sector Lexaria Bioscience Corp has the lowest Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Lexaria Bioscience Corp Segment

Price to sales ratio Company Ranking
Within: No.
Industry #0
Sector #0
S&P 500 #5






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com